Skip to content

Safe and easy application of BioComp implants for episthetic reconstruction of craniofacial defects - A pilot study

Safe and easy application of BioComp implants for episthetic reconstruction of craniofacial defects - A pilot study - BioComp implants in anaplastology

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON55796
Enrollment
10
Registered
2015-03-13
Start date
2018-01-25
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

craniofacial defects

Interventions

Depending on the craniofacial region, 2-4 implants will be placed directly after ablation surgery of the ear, nose or eye/orbital cavity. The exact location of the implants will be planned pre-opera

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age 18-85 in need of a craniofacial epithesis able to maintain a good personal hygiene

Exclusion criteria

Exclusion criteria: unable to maintain a good personal hygiene psychiatric disorders acute infection immunosuppresion compromised by medication pregnancy local irradiation >50gray

Design outcomes

Primary

MeasureTime frame
The main study parameter is implant stability, measured with the Osstell® implant stability instrument using resonance frequency analysis. Implant stability is related with the rate of osseointegration around the implant. Bone quantity/quality and the level of osseointegration will also be radiologically evaluated with a cone beam CT.

Secondary

MeasureTime frame
Secundary parameters/outcomes are implant survival, epithethic survival, easiness of use, patient satisfaction and quality of life, skin reactions and occuring complications.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)